Welcome to the Inaugural FcRn-Targeted Therapies for Autoimmune Disorders Summit
The 3-day program will bring together a wealth of knowledge into the complexities of the FcRn-IgG interaction and the therapeutic strategies which are being employed to yield clinical efficacy. Expect to hear from industry leaders showcasing clinical candidates aimed at disrupting the autoantibody interaction and increasing the clearance of pathogenic IgG from the body.
Attend this event to:
Understand the fundamentals of FcRn biology and IgG recycling with Jan Terje Anderson, University of Oslo
Analyze the PBPK parameters of FcRn-mediated binding and recycling with Armin Sepp, GlaxoSmithKline plc.
Understand the nuances of the FcRn-recycling system to antagonize FcRn function with Anne Verhagen, CSL Research
Hear the latest on how engineering the Fc domain can allow for improved pH-dependent binding with Tilman Schlothauer, Roche
View unique clinical case studies from UCB, Argenx, and Alexion Pharmaceuticals to invigorate your own pipeline to deliver best in care medicines to autoimmune and rare disorder patients